Current and Emerging Options for the Management of Inherited von Willebrand Disease

von Heijdra, Jessica M., Cnossen, Marjon H., Leebeek, Frank W. G.
Veröffentlicht in Drugs (2017)

Impact of extreme weight loss on factor VIII concentrate pharmacokinetics in haemophilia

von van Moort, Iris, Bukkems, Laura H, Nieuwenhuizen, Laurens, Cnossen, Marjon H
Veröffentlicht in BMJ Case Rep (2021)

Pharmacokinetic-guided dosing of factor VIII concentrate in a morbidly obese severe haemophilia A patient undergoing orthopaedic surgery

von Preijers, Tim, Laros-vanGorkom, Britta AP, Mathôt, Ron AA, Cnossen, Marjon H
Veröffentlicht in BMJ Case Rep (2019)

Circadian Variation of Plasminogen-Activator-Inhibitor-1 Levels in Children with Meningococcal Sepsis

von Boeddha, Navin P., Driessen, Gertjan J., Cnossen, Marjon H., Hazelzet, Jan A., Emonts, Marieke
Veröffentlicht in PLoS One (2016)

Pharmacokinetic-guided dosing of factor VIII concentrate in a patient with haemophilia during renal transplantation

von Hazendonk, Hendrika C A M, Kruip, Marieke J H A, Mathôt, Ron A A, Cnossen, Marjon H
Veröffentlicht in BMJ Case Rep (2016)

A randomized controlled trial studying the effectiveness of group medical appointments on self-efficacy and adherence in sickle cell disease (TEAM study): study protocol

von Madderom, Marlous J., Heijdra, Jessica, Utens, Elisabeth M. W. J., Polinder, Suzanne, Rijneveld, Anita W., Cnossen, Marjon H.
Veröffentlicht in BMC Hematol (2016)

Criteria for low von Willebrand factor diagnosis and risk score to predict future bleeding

von Atiq, Ferdows, Wuijster, Esmee, de Maat, Moniek P.M., Kruip, Marieke J.H.A., Cnossen, Marjon H., Leebeek, Frank W.G.
Veröffentlicht in J Thromb Haemost (2021)

Improving access to healthcare for paediatric sickle cell disease patients: a qualitative study on healthcare professionals’ views

von Houwing, Maite E., Buddenbaum, Marit, Verheul, Thijs C. J., de Pagter, Anne P. J., Philipsen, Jacobus N. J., Hazelzet, Jan A., Cnossen, Marjon H.
Veröffentlicht in BMC Health Serv Res (2021)

Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia

von Preijers, Tim, Schütte, Lisette M., Kruip, Marieke J. H. A., Cnossen, Marjon H., Leebeek, Frank W. G., van Hest, Reinier M., Mathôt, Ron A. A.
Veröffentlicht in Clin Pharmacokinet (2020)

Analytical variation in factor VIII one‐stage and chromogenic assays: Experiences from the ECAT external quality assessment programme

von van Moort, Iris, Meijer, Piet, Priem‐Visser, Debby, van Gammeren, Adriaan J., Péquériaux, Nathalie C. V., Leebeek, Frank W. G., Cnossen, Marjon H., de Maat, Moniek P. M.
Veröffentlicht in Haemophilia (2018)

The one‐stage assay or chromogenic assay to monitor baseline factor VIII levels and desmopressin effect in non‐severe haemophilia A: Superiority or non‐inferiority?

von Schütte, Lisette M., Hodes, Luca S., van Moort, Iris, Stoof, Sara C. M., Leebeek, Frank W. G., Cnossen, Marjon H., de Maat, Moniek P. M., Kruip, Marieke J. H. A.
Veröffentlicht in Haemophilia (2020)

von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD

von Atiq, Ferdows, Schütte, Lisette M., Looijen, Agnes E. M., Boender, Johan, Cnossen, Marjon H., Eikenboom, Jeroen, de Maat, Moniek P. M., Kruip, Marieke J. H. A., Leebeek, Frank W. G.
Veröffentlicht in Blood Adv (2019)

Identifying Children with HEreditary Coagulation disorders (iCHEC): a protocol for a prospective cohort study

von Stokhuijzen, Eva, Rand, Margaret L, Cnossen, Marjon H, Biss, Tina T, James, Paula D, Suijker, Monique H, Peters, Marjolein, van der Lee, Johanna H, Peters, Bram, Meijer, Alexander B, Blanchette, Victor S, Fijnvandraat, Karin
Veröffentlicht in BMJ Open (2018)

Silent cerebral infarcts in patients with sickle cell disease: a systematic review and meta-analysis

von Houwing, Maite E., Grohssteiner, Rowena L., Dremmen, Marjolein H. G., Atiq, Ferdows, Bramer, Wichor M., de Pagter, Anne P. J., Zwaan, C. Michel, White, Tonya J. H., Vernooij, Meike W., Cnossen, Marjon H.
Veröffentlicht in BMC Med (2020)

Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study

von Saes, Joline L., Verhagen, Marieke J. A., Meijer, Karina, Cnossen, Marjon H., Schutgens, Roger E. G., Peters, Marjolein, Nieuwenhuizen, Laurens, van der Meer, Felix J. M., Kruis, Ilmar C., van Heerde, Waander L., Schols, Saskia E. M.
Veröffentlicht in Blood Adv (2020)

BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease

von Atiq, Ferdows, Fijnvandraat, Karin, van Galen, Karin P. M., Laros‐Van Gorkom, Britta A. P., Meijer, Karina, de Meris, Joke, Coppens, Michiel, Mauser‐Bunschoten, Eveline P., Cnossen, Marjon H., van der Bom, Johanna G., Eikenboom, Jeroen, Leebeek, Frank W. G.
Veröffentlicht in Am J Hematol (2019)

Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease

von Boender, Johan, Atiq, Ferdows, Cnossen, Marjon H., van der Bom, Johanna G., Fijnvandraat, Karin, de Meris, Joke, de Maat, Moniek P. M., van Galen, Karin P. M., Laros-van Gorkom, Britta A. P., Meijer, Karina, Eikenboom, Jeroen, Leebeek, Frank W. G.
Veröffentlicht in Hemasphere (2021)

Population pharmacokinetics of the von Willebrand factor–factor VIII interaction in patients with von Willebrand disease

von Bukkems, Laura H., Heijdra, Jessica M., de Jager, Nico C. B., Hazendonk, Hendrika C. A. M., Fijnvandraat, Karin, Meijer, Karina, Eikenboom, Jeroen C. J., Laros-van Gorkom, Britta A. P., Leebeek, Frank W. G., Cnossen, Marjon H., Mathôt, Ron A. A.
Veröffentlicht in Blood Adv (2021)

One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P(®)/Humate P(®) treatment in von Willebrand disease patients

von de Jager, Nico C. B., Bukkems, Laura H., Heijdra, Jessica M., Hazendonk, Carolien H. C. A. M., Fijnvandraat, Karin, Meijer, Karina, Eikenboom, Jeroen, Laros ‐ van Gorkom, Britta A. P., Leebeek, Frank W. G., Cnossen, Marjon H., Mathôt, Ron A. A., Collins, P. W.
Veröffentlicht in J Thromb Haemost (2019)

Dosing of factor VIII concentrate by ideal body weight is more accurate in overweight and obese haemophilia A patients

von van Moort, Iris, Preijers, Tim, Hazendonk, Hendrika C.A.M., Schutgens, Roger E.G., Laros‐van Gorkom, Britta A.P., Nieuwenhuizen, Laurens, van der Meer, Felix J.M., Fijnvandraat, Karin, Leebeek, Frank W.G., Meijer, Karina, Mathôt, Ron A.A., Cnossen, Marjon H.
Veröffentlicht in Br J Clin Pharmacol (2020)